Ironman Stock

<div style="background-color: none transparent;"><a href="http://www.rsspump.com/?web_widget/rss_widget/twitter_widget" title="web widget">Twitter Widget</a></div>

Hemiwedge Industries, Inc. (Pink Sheets: HWEG), RECOMMENDATION: BUY HWEG a global supplier of engineered valves focused in the oil/gas production, refining, mining, process, pipeline, power, mid-stream and petro-chemical markets, issued the following marketing and operations update today of the Company's progress on behalf of its shareholders. Since the Company's update release in March 2010, the Company has acquired new customers domestically and internationally and continued to grow and improve operations. Second Quarter and Six Months ending June 2010 Revenues Unaudited revenues for the second quarter ending June 30, 2010 were approximately $575,000, or an increase of 164%, as compared to the second quarter 2009. Revenues for the first six months ending, June 30, 2010 were approximately $1.61 million, or an increase of 352%, compared to the first six months ending June 2009. Based on second quarter customer indications and industry activity levels in the market, the Company currently continues to estimate significant revenue growth in 2010 and beyond. The industrial valve market segments that Hemiwedge Valve Corp. are focused in continue to show signs of improvement from their 2009 lows. While management did not see as many capital expansion projects by its customers during the second quarter, indications are these projects will move forward in the later half of this year and next year. Many of the company's current orders represent maintenance purchases and replacement of legacy ball valves products with which we compete. Current backlog of purchase orders received, not yet shipped, totaled approximately $640,000 at June 30, 2010. The customers associated with this backlog include a multi-national energy services customer, an overseas managed pressure drilling company, a chemical process company, domestic refiners, and products pipeline companies. New Customers and New Applications for Hemiwedge(R) Cartridge valve. The marketplace acceptance of the Company's patented Hemiwedge(R) Cartridge valve product line continues to be confirmed, particularly in severe service applications where legacy products fail prematurely and customers many times are actively seeking new product solutions. One of Hemiwedge's significant new customer wins recently includes a global refinery company. This $75 billion market cap company sought our Hemiwedge Cartridge valve product for catalyst fines applications. Repeat orders since the last Company update press release have been in several applications including chemical processing, pipeline and mid-stream applications.

Free Search Engine Submission

MSLP — Muscle Pharm Corp (Pink Sheets: MSLP) RECOMMENDATION: BUY a fast-growing nutritional supplement company with a proprietary formulation used in eight performance products, today announced that the Company has been invited by The National Association of People with AIDS (NAPWA) to present at its non-commercial satellite symposium: Research Advances from Therapeutic Vaccines and Other Based Therapies Community Forum on July 22, 2010 at the XVIII International AIDS Conference in Vienna, Austria. "We are pleased that the NAPWA has invited us to participate in this important conference. We have a strong scientific research & development team that utilizes a scientific six-step program to make sure that our products are safe and effective," commented Brad Pyatt, CEO of MusclePharm Corporation. "To be part of this conference is an important endorsement of our business model and product development process," continued Brad Pyatt. Mariel Selbovitz, MPH will be presenting on behalf of MusclePharm on emerging evidence that the Company's RE-CON product has shown clinical attributes that dramatically address the involuntary weight loss and catabolic cachexia in HIV patients on HAART (highly active antiretroviral therapy). These patients are at risk for the pathogenesis, transmigration and proliferation of resistant profiles of minority subspecies, provoking increased ratios of adverse proinflammatory cytokine ratios that are inversely correlated, as afforded by peer-reviewed literature, with a clear etiological pathway of morbid disease progression. Catabolic cachexia, also known as AIDS related wasting syndrome, has historically been a leading cause of characteristic disease progression in AIDS patients. Cachexia is difficult to treat and typical interventions do not consistently translate to sustainable clinical benefits. Additionally, prophylactic therapeutic nutritional supplementation has been identified as one of the most cost effective interventions to prevent predictable related disease progression. New York and other state Medicaid programs, as well as AIDS drug assistance programs and nation-wide Veterans Administration therapeutic formularies, all recognize the value of therapeutic nutritional supplementation interventions for the treatment of catabolic cachexia, the prognostic markers of which are associated with loss of appetite, uncontrolled diarrhea, macro and micronutrient deficiencies, abnormal cytokine presentation, proinflammatory oxidative stress and decreased caloric intake. Several reports of observed clinical improvement in U.S. AIDS patients in outpatient settings indicate that (RE-CON) in conjunction with Medicaid approved sources of whey protein and HMB intake have dramatically increased lean body mass in patients diagnosed with catabolic cachexia, with definitive correlations to the prevention of the onset of HIV drug resistance. Clinical studies to further examine this phenomenon are now being planned by leading clinicians and community advocates in multi-site trials across the U.S. and Europe. A proposal for the federal facilitation of these studies is being prepared for the Adult AIDS Clinical Trials Group at the National Institute of Allergy and Infectious and Diseases, National Institutes of Health.

Simulated Environment Concepts (PINK SHEETS: SMEV) RECOMMENDATION: BUY Simulated Environment Concepts, Inc. is the U.S. based manufacturer of SpaCapsule and Celude products. The company's doctors, with 40 years of combined professional experience, created the most perfect system for weight loss, anti-cellulite, massage, anti-aging, and de-stressing. This non-invasive technology is called the SpaCapsule. Combined with Celude products it offers complete bio-mechanical and bio-chemical systems to combat cellulite, weight gain and fatigue. SpaCapsule can be deployed in a corporate environment, as a Corporate Wellness Program; or it provides unattended, self-automated treatments for Health, Beauty, Wellness, Fitness and Sport Industries.

eDOORWAYS Corp.(PINK SHEETS: EDWY) RECOMMENDATION: BUY The eDoorways platform is a revolutionary business to consumer social network website integrating advanced search technologies to create an exciting new brand, solving lifestyle problems for consumers and driving traffic through the physical and/or virtual doorways of goods and service providers. What gives eDoorways a uniquely competitive advantage is the value add of next generation networking interface that delivers a real-time collaborative problem-solving venue with capabilities for instantaneously sourcing correct information, products, services and solutions. This platform will save consumers valuable personal resources by uniting them with the global consumer community, retailers, and manufacturers in an effective new way while generating revenue via sponsorship and transactions completed during consumer visits.

N-Viro International Corporation (OTC Bulletin Board:NVIC.OB RECOMMENDATION: BUY NVIC announced today it has entered into a new supply agreement with FirstEnergy Corporation (NYSE:FE - News) for a portion of the reagent used at its Toledo, Ohio facility currently producing N-Viro Soil™.Under the terms of this agreement, N-Viro will provide transportation services and receive reagents from FirstEnergy into its Toledo, Ohio facility. N-Viro intends to utilize these reagents to further enhance their N-Viro Soil™ product while further improving the operational efficiencies of their Toledo, Ohio facility. This agreement complements N-Viro's current sources of supply and provides enhanced logistical efficiencies. CEO and President of N-Viro International, Mr. Timothy R. Kasmoch, had these comments: "We have worked for some time to reach this arrangement with FirstEnergy. The close proximity of their facilities will improve the efficiencies of our transportation subsidiary, Bio Mineral Transportation, and believe it will ultimately improve the profitability of the transportation of our additives. Together with our existing reagent suppliers, we believe we have improved our planning and operational profiles. We are also very pleased to be working with such a high stature, local company as FirstEnergy." About N-Viro International (http://www.nviro.com/) N-Viro International is an environmental and materials operating company that owns patented technologies to convert various types of waste into beneficial alternative fuel products. Its renewable biofuel technology, N-Viro Fuel™, has received alternative energy status from the U.S. Environmental Protection Agency, which qualifies the technology for renewable energy incentives. N-Viro operates processing facilities independently as well as in partnership with municipalities. N-Viro maintains a web site at http://www.nviro.com/, where interested parties can follow the progress of the Company. N-Viro will continue to routinely post press releases on the site and encourages stockholders and interested parties to monitor the site on a regular basis

Silver America, Inc. (OTCBB: SILA) RECOMMENDATION: BUY
changed its name to Gold American Mining Corp. ("Gold American" and/or "the Company") to better reflect the nature and primary focus of its business operations. The name change was effected as a result of the Company's more specific emphasis on exploring for gold within the precious metals industry, and the belief that it would be in the best interest of the Company and its shareholders. The Company's shares continue to trade on the OTC BB under the symbol SILA and a new corporate website has been launched at www.gold-american.com.
The Company's current holdings include the Nevada-based Keeno Strike Property and the Guadalupe Property in Mexico, located roughly 5 miles north of the Fresnillo (Proano) Mine. The Company also remains committed to its aggressive, ongoing acquisition of holdings with rich gold and silver production potential. Toward that end, Gold American is currently reviewing additional gold/silver prospects of interest in Nevada, Mexico and other regions marked by stable politics, sound economies and friendly business relations.
ABOUT GOLD AMERICAN MINING CORP. Gold American Mining Corp. is a publicly traded (OTCBB: SILA) precious metals exploration company focused on the aggressive, ongoing acquisition and exploration of holdings with rich gold and silver production potential. Based in Reno, Nevada, Gold American has developed a promising portfolio of international properties in regions marked by stable politics, sound economies and friendly business relations. For more information the Company and its projects, visit Gold American's website at www.gold-american.com.

Main Navigation